ImmunoPhotonics Competitors and Similar CompaniesClear all
ImmunoPhotonics's competitors and similar companies include Epizyme, Loxo Oncology, Achilles Therapeutics and Italfarmaco.
 ImmunoPhotonics Immunophotonics is a biotechnology company developing a proprietary carbohydrate polymer. |  Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations. |  Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. |  Italfarmaco Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas. | |
Founding Date | Founding Date 2008 | Founding Date 2007 | Founding Date 2013 | Founding Date 2016 | Founding Date 1938 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations St. Louis, US HQ | Locations Cambridge, US HQ | Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US | Locations London, GB HQ Stevenage, GB | Locations Cinisello Balsamo, IT HQ Paleo Faliro, GR Milano, IT Algés, PT Moskva, RU Alcobendas, ES Berwyn, US |
Employees | Employees 18 | Employees 20364% increase | Employees 65610% decrease | Employees 695% decrease | Employees 3,043 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($251.1m) (FY, 2021) | Net income ($148.9m) (FY, 2017) | Net income ($69.7m) (FY, 2023) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 600k (over 11 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 121m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 3.1m | Total funding raised $ 51.5m | Total funding raised $ 57m | Total funding raised $ 138.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View companyLoxo Oncology
HQ
Stamford, US
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
View companyAchilles Therapeutics
HQ
London, GB
Employees
69↓ 5% decrease
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View companyItalfarmaco
HQ
Cinisello Balsamo, IT
Employees
3,043
Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas.
View company